NPN Log

New Delhi: A solution has been found to combat the dengue epidemic that poses a challenge to public health. For the first time in the country, a vaccine for dengue prevention is set to become available. The Drug Controller General of India (DCGI) has granted approval to launch 'Qdenga'—a vaccine developed by the renowned Japanese biopharmaceutical company Takeda—in the Indian market. Takeda Biopharmaceuticals India Private Limited announced this development.

You Might Also Like

Comments

Leave A Comment

Don’t worry ! Your email address will not be published. Required fields are marked (*).